KRAS and neoplasm: The RAS/RAF/MEK/ERK and PI3K/AKT/mTOR cascades represent key signaling routes whose dysregulation contributes to tumor growth, survival, and therapeutic resistance in tumors harboring alterations such as KRAS, BRAF, PIK3CA, or PTEN.